Dyslipidemia is a major risk factor contributing ... a process that is central to the pathogenesis of atherosclerosis. In ART-naive patients, the proinflammatory state may contribute to mortality ...

To determine whether torcetrapib, a CETP inhibitor, could prevent the progression of carotid atherosclerosis in patients with mixed dyslipidemia, an international group of researchers conducted a ...

Over a 9-year follow-up period from adolescence to young adulthood, elevated lipid and dyslipidemia levels were associated with worsening subclinical atherosclerosis. However, using a temporal ...

A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...

The findings, published in Nature Cardiovascular Research, suggest that the response to the onset of atherosclerosis begins ...

It is clear that issues surrounding atherosclerosis and cardiovascular ... a unifying single measure to reflect the contribution of dyslipidemia to CVD makes it difficult to determine the benefit ...